Liver Cancer-Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma.
Lu F, Shah PA, Rao A, Gifford-Hollingsworth C, Chen A, Trey G, Soryal M, Talat A, Aslam A, Nasir B, Choudhry S, Ishtiaq R, Sanoff H, Conteh LF, Noonan A, Hu KQ, Schmidt C, Fu M, Civan J, Xiao G, Lau DT, Lu X.
Lu F, et al. Among authors: talat a.
Clin Transl Gastroenterol. 2020 Dec;11(12):e00271. doi: 10.14309/ctg.0000000000000271.
Clin Transl Gastroenterol. 2020.
PMID: 33512798
Free PMC article.